Banque Cantonale Vaudoise’s Oncolytics Biotech ONCY Stock Holding History

Banque Cantonale Vaudoise’s Portfolio ONCY Stock Details ONCY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-11,900	Closed	-$12K	–	940
2024 Q2	$12K	Hold	11,900	–	–	﹤0.01%	927
2024 Q1	$13K	Hold	11,900	–	–	﹤0.01%	920
2023 Q4	$16K	Hold	11,900	–	–	﹤0.01%	916
2023 Q3	$26K	Hold	11,900	–	–	﹤0.01%	1039
2023 Q2	$31K	Hold	11,900	–	–	﹤0.01%	1034
2023 Q1	$14K	Hold	11,900	–	–	﹤0.01%	1092
2022 Q4	$19K	Buy	11,900 +632	+6%	+$960	﹤0.01%	1071
2022 Q3	$15K	Hold	11,268	–	–	﹤0.01%	1124
2022 Q2	$11K	Hold	11,268	–	–	﹤0.01%	1177
2022 Q1	$18K	Hold	11,268	–	–	﹤0.01%	1161
2021 Q4	$16K	Hold	11,268	–	–	﹤0.01%	1207
2021 Q3	$24K	Hold	11,268	–	–	﹤0.01%	1144
2021 Q2	$31K	Hold	11,268	–	–	﹤0.01%	1113
2021 Q1	$42K	Buy	11,268 +9,900	+724%	+$29.5K	﹤0.01%	1012
2020 Q4	$3K	Hold	1,368	–	–	﹤0.01%	1057
2020 Q3	$2K	Buy	+1,368	New	+$2.51K	﹤0.01%	1043

Other funds holding ONCY

IAIM

International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return

Seeds Investor New York $735M AUM 17.54% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

CIBC World Market Toronto, Ontario, Canada $61.3B AUM 39.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Banque Cantonale Vaudoise's ONCY Position: Q3 2024 in Review

Banque Cantonale Vaudoise sold out of Oncolytics Biotech (ONCY) in Q3 2024, closing a stake of 11,900 shares — an estimated $12K sold.

Banque Cantonale Vaudoise first reported a position in ONCY in Q3 2020 and held it in 16 quarters. The position peaked at $42K in Q1 2021. 42 funds tracked by Wall St. Rank hold ONCY as of Q3 2024.

Banque Cantonale Vaudoise reported no remaining Oncolytics Biotech position as of Q3 2024 after selling out during the quarter.
Banque Cantonale Vaudoise sold 11,900 Oncolytics Biotech shares in Q3 2024, an estimated $12K.
Banque Cantonale Vaudoise first reported a position in Oncolytics Biotech in Q3 2020 and held it in 16 quarters.
Banque Cantonale Vaudoise's Oncolytics Biotech position peaked at $42K in Q1 2021.
42 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q3 2024.

Based on Banque Cantonale Vaudoise's 13F filing for Q3 2024, filed 8 Nov 2024.